THE IT&S 2015 ANNUAL REPORT
2015AnnualReport
2015AnnualReport
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
<strong>2015</strong> Accomplishments<br />
The cancer registrar and cancer navigator are two key roles<br />
who interact with cancer patients at HCA, and this year several<br />
advancements in core systems are making a difference in the big<br />
picture of cancer care.<br />
Sarah Cannon Research<br />
Institute (SCRI)<br />
CIO: ANDY CORTS<br />
Sarah Cannon Research Institute is the research arm of HCA’s<br />
global cancer institute. Focused on advancing therapies for<br />
patients, it is one of the world’s leading clinical research<br />
organizations, conducting community-based clinical trials<br />
through affiliations with a network of more than 1,000 physicians<br />
across the United States and United Kingdom. Sarah Cannon<br />
has led approximately 200 first-in-man clinical trials since its<br />
inception in 1993 and has been a clinical trial leader in nearly<br />
80 percent of approved cancer therapies in the last ten years.<br />
Additionally, Sarah Cannon offers management, regulatory,<br />
and other research support services for drug development and<br />
industry sponsors as well as strategic investigator sites.<br />
CANCER REGISTRY<br />
A cancer registry is a systematic collection of data about cancer<br />
and tumor diseases and is collected by cancer registrars. Cancer<br />
registrars capture a complete summary of patient history,<br />
diagnosis, treatment, and status for every cancer patient<br />
diagnosed within the HCA health system. Consolidating more<br />
than 150 registries into a single database benefits patients and<br />
cancer care in a number of ways.<br />
• STANDARDIZED ANALYTICS • AVAILABILITY OF MARKET<br />
ON 1.9 MILLION UNIQUE<br />
AND ENTERPRISE DATA<br />
CANCER PATIENTS SUPPORTS ALLOWS FOR IMPROVED<br />
ANALYTICS ON CLINICAL<br />
ANALYSIS AND <strong>REPORT</strong>ING<br />
OUTCOMES AND QUALITY OF<br />
(PARTICULARLY REFERRAL<br />
CARE.<br />
PATTERNS), GREATER<br />
INSIGHT INTO MIGRATION<br />
• PLATFORM<br />
OF PATIENTS TO COMPETING<br />
STANDARDIZATION REDUCES<br />
HOSPITALS, AND ADHERENCE<br />
CANCER REGISTRY SUPPORT<br />
TO NATIONAL QUALITY<br />
COSTS BY $300,000 A YEAR<br />
METRICS.<br />
ACROSS HCA.<br />
• CONCURRENT COLLECTION<br />
• STANDARDIZED<br />
OF QUALITY METRICS<br />
OPERATIONS SIMPLIFIES<br />
FACILITATES DATA REVIEW<br />
COMPLIANCE WITH<br />
PRIOR TO SUBMISSION TO<br />
NATIONAL ACCREDITATION<br />
<strong>THE</strong> NATIONAL CANCER<br />
REQUIREMENTS,<br />
DATABASE.<br />
POTENTIALLY ENABLING<br />
MORE CANCER PROGRAMS<br />
TO BECOME ACCREDITED.<br />
48<br />
49